These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37660436)

  • 1. Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.
    Li X; Song X; Mahmood DFD; Sim MMS; Bidarian SJ; Wood JP
    Thromb Res; 2023 Oct; 230():84-93. PubMed ID: 37660436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg
    van Doorn P; Rosing J; Wielders SJ; Hackeng TM; Castoldi E
    J Thromb Haemost; 2017 Jan; 15(1):140-149. PubMed ID: 27801970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.
    Dahlbäck B
    J Thromb Haemost; 2017 Jul; 15(7):1241-1250. PubMed ID: 28671348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V and thrombotic disease: description of a janus-faced protein.
    Nicolaes GA; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
    Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
    J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of human factor Va inactivation by activated protein C.
    Bravo MC; Orfeo T; Mann KG; Everse SJ
    BMC Syst Biol; 2012 May; 6():45. PubMed ID: 22607732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
    van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
    Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
    Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
    Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.
    Koshiar RL; Somajo S; Norström E; Dahlbäck B
    PLoS One; 2014; 9(8):e104200. PubMed ID: 25136857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
    Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
    Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.
    Stavenuiter F; Davis NF; Duan E; Gale AJ; Heeb MJ
    Thromb Haemost; 2013 Feb; 109(2):229-37. PubMed ID: 23238804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
    Ayombil F; Petrillo T; Kim H; Camire RM
    J Biol Chem; 2022 Nov; 298(11):102558. PubMed ID: 36183835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets.
    Briedé JJ; Tans G; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 2001 Mar; 276(10):7164-8. PubMed ID: 11113137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα.
    van Doorn P; Rosing J; Campello E; Middeldorp S; Simioni P; Meijers JCM; Hackeng TM; Castoldi E
    Thromb Haemost; 2020 Jan; 120(1):55-64. PubMed ID: 31705518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.
    Wood JP; Petersen HH; Yu B; Wu X; Hilden I; Mast AE
    Blood Adv; 2017 Dec; 1(27):2692-2702. PubMed ID: 29291252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down regulation of prothrombinase by activated protein C during prothrombin activation.
    Kim PY; Nesheim ME
    Thromb Haemost; 2010 Jul; 104(1):61-70. PubMed ID: 20390226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.